Hideyuki Wakabayashi
- Immunology and Allergy top 10%
- Food Allergy and Anaphylaxis Research 2
- Food Science top 5%
- Probiotics and Fermented Foods 2
- Dermatology top 10%
-
- Gastrointestinal Tumor Research and Treatment 2
-
- Multiple and Secondary Primary Cancers 2
-
- Colorectal and Anal Carcinomas 2
-
- Metastasis and carcinoma case studies 2
-
- Asthma and respiratory diseases 2
-
- Microbial Metabolites in Food Biotechnology 1
- Co-authors
- Daisuke FujiwaraSayo InoueToshio FujiiHiroyuki WatanabeHisakazu IinoSatoshi NishidaYoshimasa TaniguchiHiroaki Yajima
- Partner nations
- Japan
In The Last Decade
Hideyuki Wakabayashi
11 papers receiving 332 citations
Peers
Comparison fields: 5 of 64
- Immunology and Allergy 87
- Food Science 174
- Dermatology 48
- Gastroenterology 19
- Microbiology 17
Countries citing papers authored by Hideyuki Wakabayashi
This map shows the geographic impact of Hideyuki Wakabayashi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideyuki Wakabayashi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideyuki Wakabayashi more than expected).
Fields of papers citing papers by Hideyuki Wakabayashi
This network shows the impact of papers produced by Hideyuki Wakabayashi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideyuki Wakabayashi. The network helps show where Hideyuki Wakabayashi may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Hideyuki Wakabayashi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2021 | 1 | |
| 3 | 2014 | 28 | |
| 4 | 2014 | 19 | |
| 5 | 2013 | 26 | |
| 6 | [A case of advanced esophageal carcinoma with nephrotic syndrome completely responding to chemotherapy of docetaxel, nedaplatin and 5-fluorouracil]. | 2011 | 1 |
| 7 | 2011 | 1 | |
| 8 | [A case of double advanced cancer with esophageal and hypopharyngeal carcinoma responding completely to combination chemotherapy of docetaxel/5-fluorouracil and nedaplatin with radiation]. | 2009 | 1 |
| 9 | 2007 | 41 | |
| 10 | 2005 | 25 | |
| 11 | 2004 | 211 |
About Hideyuki Wakabayashi
Hideyuki Wakabayashi is a scholar working on Gastroenterology, Immunology and Allergy and Microbiology, having authored 11 papers that have together received 355 indexed citations. Recurring topics across this work include Food Allergy and Anaphylaxis Research (2 papers), Multiple and Secondary Primary Cancers (2 papers), Colorectal and Anal Carcinomas (2 papers), Gastrointestinal Tumor Research and Treatment (2 papers), Probiotics and Fermented Foods (2 papers), Metastasis and carcinoma case studies (2 papers), Asthma and respiratory diseases (2 papers) and Microbial Metabolites in Food Biotechnology (1 paper). The work is most often cited by research in Immunology and Allergy (87 citations), Food Science (174 citations) and Dermatology (48 citations). Hideyuki Wakabayashi has collaborated with scholars based in Japan. Frequent co-authors include Daisuke Fujiwara, Sayo Inoue, Toshio Fujii, Hiroyuki Watanabe, Hisakazu Iino, Satoshi Nishida, Yoshimasa Taniguchi, Hiroaki Yajima, Aruto Yoshida and Kazutoshi Shindo.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.